ANIP News and Press, ANI Pharmaceuticals Inc. From 11/05/20

ANI Pharmaceuticals (ANIP): Q3 Non-GAAP EPS of $0.97 beats by $0.09; GAAP EPS of $0.04 beats by $0.14.Revenue of $52.98M (+3.2% Y/Y) beats by $1.48M.Press Release For further details see: ANI Pharmaceuticals EPS beats by $0.09, beats on revenue

- Third quarter 2020 net revenues of $53.0 million; net income of $0.4 million and diluted eps of $0.04 - - Third quarter adjusted non-GAAP EBITDA of $17.0 million and adjusted non-GAAP diluted eps of $0.97 - - Cortrophin ® Gel sNDA re-filing on track; commerc...

ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today announced that the Company will release its third quarter 2020 financial results on Thursday, November 5, 2020, before the opening of the U.S. financial markets. Nikhil Lalwani, Presi...

ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq: ANIP) today announced that the Compensation Committee of ANI’s Board of Directors granted a non-qualified inducement stock option to purchase an aggregate of 179,643 shares of ANI’s common st...

ANI Pharmaceuticals, Inc. (ANIP) Q2 2020 Results Conference Call August 06, 2020 10:30 AM ET Company Participants Lisa Wilson - In-Site Communications, IR Patrick Walsh - Interim President and CEO Stephen Carey - CFO Conference Call Participants Brandon Folkes - Cantor Fitz...

Image source: The Motley Fool. ANI Pharmaceuticals Inc   (NASDAQ: ANIP) Q2 2020 Earnings Call Aug 6, 2020 , 10:30 a.m. ET Operator Continue reading

ANI Pharmaceuticals (NASDAQ: ANIP ) : Q2 Non-GAAP EPS of $0.69 misses by $0.06 ; GAAP EPS of -$1.03 misses by $1.19 . More news on: ANI Pharmaceuticals, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

- Second quarter 2020 net revenues of $48.5 million - - Nikhil Lalwani named President and CEO, effective September 8, 2020 – - Pharmaceutical industry executives, Jeanne Thoma and Tony Pera, join Board of Directors - ANI Pharmaceuticals, Inc. (“ANI” or ...

Additions reflect ANI’s commitment to broaden pharmaceutical industry experience on Board ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (Nasdaq:ANIP) today announced the appointments of Jeanne Thoma, President and Chief Executive Officer of SPI P...

Effective September 8, ANI Pharmaceuticals (NASDAQ: ANIP ) appoints  Nikhil Lalwani as President and CEO succeeding Patrick D. Walsh More news on: ANI Pharmaceuticals, Inc., Healthcare stocks news, Read more ...